Autonomic Nervous System (ANS) Testing Equipment
Secure Health, Inc. is pleased to offer Autonomic Nervous System (ANS) diagnostic equipment by Intellewave. Please click here for a 17 page PDF of the ANS equipment. Note: The PDF is 10+ MB.
ANS Testing: A 15 minute test in your office--no interpretations needed
ANS Testing:
Provides quantitative assessments of the
autonomic nervous system
Distinguishes between early and late stages
of autonomic neuropathy
Recognizes up to 81 different variations in
the relationship between sympathetic and parasympathetic activities.
A functional understanding of ANS enables you to:
Monitor and predict general responses
to a variety of stimuli
Explain responses to changes in environmental conditions
Manage symptoms that result from abnormal
autonomic functions
Understand how drugs affect the ANS |
ANS testing helps you objectively confirm
or exclude:
Cardiovascular Autonomic Neuropathy (CAN)
Diabetic Autonomic Neuropathy (DAN)
Syncope
Dizziness
Distinguish between early and late stages
of autonomic neuropathy
Better monitor patient’s beta-blocker regime overdose cases
Other dysautonomia problems |
Early detection of ANS imbalances helps broaden treatment options:
Helps monitor patients’ overall health
Provides early detection of Silent
Ischemia
May help prevent unexpected sudden
cardiac death
Reimbursed by most third-party payors and Medicare
|
Patients that most benefit from ANS testing have:
Diabetes
Hypertension
Orthostatic hypotension
Cardiovascular Autonomic Neuropathy (CAN)
Syncope
Sleep apnea
Congestive heart failure
Chronic pain and more
|
ANS monitoring is recommended as a standard
of care by the AAN, ADA, AHA, AAFP, Juvenile
Diabetes Association, National Heart, Lung and Blood Institute and the National Diabetes,
Digestive and Kidney Diseases
A Non-Invasive Quantitative Assessment of the Autonomic Nervous System
IntelleWave is a fully automated cardiac monitoring device that provides quantitative assessment of the Autonomic Nervous System (ANS) on the basis of R-R interval variability and blood pressure analysis. The system is used to objectively confirm or exclude a Cardiovascular Autonomic Neuropathy (CAN), a Diabetic Autonomic Neuropathy (DAN), syncope, dizziness and other dysautonomia problem.
It is able to distinguish between the early and late stages of autonomic neuropathy.
System Components
• PC-ECG wireless Acquisition Device or PCECG wire device.
• Automatic blood pressure-measuring device.
• Finger Pulse Oximeter.
• Mini notebook computer with integrated
bluetooth and portable printer.
• ECG and R-R interval variability Analyzer
Software for display, measurement and
interpretation of test results.
IntelleWave is distinguished by its accuracy and speed, high reliability and ease of operation. In addition, IntelleWave can provide up to 24 hours of “real-time” quantitative ANS assessment ANS status can be monitored in a variety of settings, i.e.:
– during anesthesia
– in intensive care to see effectiveness of medication
– using implantable devices
– using ambulatory Holter – ANS status can be monitored during sleep studies to see the difference between “sleep time” and “awake time”
The system provides instant assessment of QT-interval and ST-segment of the ECG data registered during the test (consisting of 448 QRS complexes), as well as complete interpretation of 2 tests – Orthostatic test and Valsalva maneuver combined with deep breathing. A variety of data collected during the test (R-R interval variability, blood pressure and ECG readings) enables clinicians to evaluate a patient’s ANS status. Our system’s proprietary sophisticated algorithm based on artifi cial intelligence approach evaluates all components of the spectral analysis including shifting of these components during the test. The unique representation of results provided by IntelleWave allows physicians to recognize up to 81 different variations in the relationship between Sympathetic and Parasympathetic activities. The system uses Cartesian system of coordinates with high-frequency (HF) Parasympathetic intensity on the horizontal axis and low-frequency (LF) Sympathetic intensity on the vertical axis. The point of intersection is interpreted as the point of Autonomic Balance.
The graphical image of this method is presented on page 2 of the PDF file. Please note that clinical decision about autonomic function can be made by combined analysis of HF(Parasympathetic) and LF(Sympathetic) relationship with blood pressure data.
Please click here for a 17 page PDF of the ANS equipment. Note: The PDF is 10+ MB.
| 
